Patents Assigned to SHANGHAI JEMINCARE PHARMACEUTICAL CO., LTD.
  • TRICYCLIC COMPOUND AS HIF2-ALPHA INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    Publication number: 20240158367
    Abstract: A tricyclic compound as represented by formula (I), a preparation method therefor, and an application thereof as an HIF2? inhibitor.
    Type: Application
    Filed: February 23, 2022
    Publication date: May 16, 2024
    Applicants: SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD, JIANGXI JEMINCARE GROUP CO., LTD
    Inventors: Pingyan BIE, Jianfeng MOU, Jianmin ZHANG, Zhengyong WAN, Qingfang YU, Zhe CHEN, Hongye LI, Jianbiao PENG
  • GARP Protein Antibody and Use Thereof
    Publication number: 20240117034
    Abstract: Provided is an GARP protein antibody, and a cell comprising or expressing the GA RP protein antibody. The GARP protein antibody binds to human GARP/human TGF-?1 complex with a KD value of about 1.0E-12 or less. Also provided are a pharmaceutical combination comprising the GARP protein antibody and an immune checkpoint inhibitor and use thereof.
    Type: Application
    Filed: January 17, 2022
    Publication date: April 11, 2024
    Applicants: SHANGHAI JEMINCARE PHARMACEUTICAL CO., LTD., JIANGXI JEMINCARE GROUP CO., LTD.
    Inventors: Jianjian ZHANG, Zhongzong PAN, Xinxiu YANG, Xiaowu LIU, Lu YANG, Peipei LIU, Xiaodan CAO, Sujun DENG, Xueping WANG
  • Tricyclic compound, preparation method therefor and use thereof
    Patent number: 11518766
    Abstract: A compound represented by formula (I), an optical isomer thereof and a pharmaceutically acceptable salt thereof, as well as an application of said compound as an FXIa inhibitor.
    Type: Grant
    Filed: June 28, 2020
    Date of Patent: December 6, 2022
    Assignees: SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD., JIANGXI JEMINCARE GROUP CO., LTD.
    Inventors: Shuchun Guo, Jiangwei Wang, Shan Yao, Yong Zhang, Zhangping Kang, Qiong Zhang, Yan Ye, Jianbiao Peng, Haibing Guo
  • Cyclic dinucleotide compound and uses thereof
    Patent number: 11401295
    Abstract: Provided are a compound of formula (I), an optical isomer thereof, a pharmaceutically acceptable salt thereof, uses of said compound acting as a STING agonist.
    Type: Grant
    Filed: October 12, 2019
    Date of Patent: August 2, 2022
    Assignees: SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD., JIANGXI JEMINCARE GROUP CO., LTD.
    Inventors: Shuchun Guo, Jianbiao Peng, Yang Liu, Haibing Guo
  • AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE
    Publication number: 20220017513
    Abstract: Relating to a compound represented by formula (I) and a pharmaceutically acceptable salt of the compound, and an application of the compound as an S1P1 agonist.
    Type: Application
    Filed: December 6, 2019
    Publication date: January 20, 2022
    Applicants: SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD, JIANGXI JEMINCARE GROUP CO., LTD
    Inventors: Hongfu LU, Jianbiao PENG, Weiqiang XING, Haibing GUO